T Edward Morris

[T Edward Morris @TEdwardMorri5]

@OmniBartonCreek sewer problems and threatening to cancel our event next week. If you have reservations call ahead.

[FARE | Food Allergy Research & Education @FoodAllergy]

A new potential treatment for peanut allergy is moving closer to @FDA review. Viaskin®, a skin patch developed by @DBVTechnologies, uses an innovative approach called epicutaneous immunotherapy (EPIT™) to deliver small amounts of peanut protein through the skin, aiming to desensitize the immune system over time.
Currently, the treatment is being studied specifically in children ages 4–7 with results expected later this year.
The FDA recently confirmed that the safety data from the current trial and its follow-up study are sufficient to support a request for FDA approval, potentially accelerating the review timeline. If approved, this patch could offer families a non-invasive option for managing peanut allergy, helping to expand food allergy treatment options.
At FARE, we’re inspired by the scientific advancements in food allergy treatment and hopeful for the positive impact they may have on those managing food allergy. #foodallergy

[T Edward Morris @TEdwardMorri5]

@buitengebieden Bite fight forever

[T Edward Morris @TEdwardMorri5]

@thepointsguy GS is the best. Awesome service at all times. United forever

[T Edward Morris @TEdwardMorri5]

@dog_rates I can burb on demand too

[T Edward Morris @TEdwardMorri5]

I pledged per goal to Every Goal Counts: Sacramento Republic FC Pledges to Fight Colon Cancer with Every Score in March on PledgeIt! https://t.co/WNNlR5GyaY

[T Edward Morris @TEdwardMorri5]

@JToussaint28 Creeper

[T Edward Morris @TEdwardMorri5]

@TexasFootball @McConaughey Alright x 3

[Humanigen, Inc. @humanigen]

Watch the latest investor presentation from Lytham Partners Spring 2022 Investor Conference available starting at 11am EDT today

https://t.co/H3sg9pbtkH

[BioWorld @BioWorld]

Biggest #biopharma #stock gainers and losers for the week of March 14-18, 2022
https://t.co/27C5M04FoM

#biotech #biotechnology #BiotechNews #LifeSciencesNews #biopharmaceutical #lifesciences #pharma

[rstar @sixonehalfdoz]

$HGEN boom! theres that million share buy! was Dale Chappell CSO of the co!!!! form 4: https://t.co/29WFzWCjFN

[stuart @stuartt30177104]

$HGEN Wow, great stock purchase, GO Dale C..@humanigen

[David Shapiro - CEO of B2i Digital, Inc. @davidshapiroNYC]

We want to welcome @Humanigen to the @ROTHCapital Conference section of b2i digital at https://t.co/KCB3U49rdI.
Humanigen has discovered, developed, and plans to commercialize LENZ®, a variant-agnostic immunomodulatory antibody, which addresses a significant unmet need in COVID.

[Humanigen, Inc. @humanigen]

Is COVID over? Not so fast. Resistance mutations found in those receiving GSK and Vir’s monoclonal for Delta, new research shows – Endpoints News https://t.co/It2zevzSFu

[NoNameMiddleAgedGuy @DevinKent17]

I wonder how long until this term becomes a part of household language? $HGEN Cytokine Storm: Symptoms, Causes, Diagnosis, and Treatment https://t.co/tDjoTQcQSj

[Peter Kolchinsky @PeterKolchinsky]

Stand up against Russia until Putin stands down in Ukraine. Business leaders, join >700 of us; take a stand, sign & RT petition to disengage from Russian industry & its elites. #StandWithUkraine #cutbizwithRussia Anyone can sign to support this action. https://t.co/xikzwpC0A3

[BirdMan @vespa1212]

$HGEN #LENZ @humanigen

https://t.co/SKOWAF0VQT

[rstar @sixonehalfdoz]

$HGEN https://t.co/67HcoOAetW lenz available in 17 European countries
"LenzMAP will enable access to lenzilumab on a case-by-case basis for hospitalized patients with COVID-19 for whom the treating physician deems there are no suitable alternatives and where regulations allow."

[rstar @sixonehalfdoz]

$hgen one million bottles of lenzilumab a year! https://t.co/f2zwGzeubr

[P1 /human @stolgic]

$HGEN more detail on the Cenexi deal announced today and future goals,